Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-05-000016
Filing Date
2005-08-12
Accepted
2005-08-12 16:22:17
Documents
5
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 BIOSANTE FORM 10Q FOR 6/30/2005 biosante10q.htm 10-Q 698180
2 CEO CERTIFICATION exhibit31w1.htm EX-31.1 13551
3 CFO CERTIFICATION exhibit31w2.htm EX-31.2 12098
4 CEO CERTIFICATION exhibit32w1.htm EX-32.1 4743
5 CFO CERTIFICATION exhibit32w2.htm EX-32.2 4648
  Complete submission text file 0001023024-05-000016.txt   734750
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 051022001
SIC: 2836 Biological Products, (No Diagnostic Substances)